These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9215817

  • 1. Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial.
    Russell CA, Green SJ, O'Sullivan J, Hynes HE, Budd GT, Congdon JE, Martino S, Osborne CK.
    J Clin Oncol; 1997 Jul; 15(7):2494-501. PubMed ID: 9215817
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide.
    Horton J, Knuiman M, Keller AM, Vogel H, Gale KE, Hahn RG, Rosenbluth RJ, Tormey DC.
    Cancer; 1987 Nov 01; 60(9):2137-40. PubMed ID: 3440224
    [Abstract] [Full Text] [Related]

  • 7. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
    Brufman G, Isacson R, Haim N, Gez E, Sulkes A.
    Oncology; 1994 Nov 01; 51(3):258-61. PubMed ID: 8196908
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A phase II evaluation of combination chemotherapy plus aminoglutethimide in women with metastatic or recurrent breast carcinoma. An Eastern Cooperative Oncology Group Pilot Study.
    Grem JL, Falkson G, Love RR, Tormey DC.
    Am J Clin Oncol; 1988 Oct 01; 11(5):528-34. PubMed ID: 3177253
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
    Muss HB, Wells HB, Paschold EH, Black WR, Cooper MR, Capizzi RL, Christian R, Cruz JM, Jackson DV, Powell BL.
    J Clin Oncol; 1988 Jul 01; 6(7):1098-106. PubMed ID: 3292710
    [Abstract] [Full Text] [Related]

  • 14. Combined endocrine treatment of postmenopausal patients with advanced breast cancer. A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone.
    Rose C, Kamby C, Mouridsen HT, Bastholt L, Brincker H, Skovgaard-Poulsen H, Andersen AP, Loft H, Dombernowsky P, Andersen KW.
    Breast Cancer Res Treat; 1986 Jul 01; 7 Suppl():S45-50. PubMed ID: 3527306
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
    Goodwin JW, Green SJ, Moinpour CM, Bearden JD, Giguere JK, Jiang CS, Lippman SM, Martino S, Albain KS.
    J Clin Oncol; 2008 Apr 01; 26(10):1650-6. PubMed ID: 18375894
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.
    Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ.
    Clin Cancer Res; 2010 Mar 15; 16(6):1904-14. PubMed ID: 20215537
    [Abstract] [Full Text] [Related]

  • 19. A randomized phase II trial of aminoglutethimide and hydrocortisone versus combined aminoglutethimide, hydrocortisone and fluoxymesterone in advanced breast cancer.
    Gennatas CS, Kalovidouris A, Paraskevas GA, Kouvaris J, Trichopoulos D, Papavasiliou C.
    Radiother Oncol; 1987 Jul 15; 9(3):217-20. PubMed ID: 3628857
    [Abstract] [Full Text] [Related]

  • 20. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Exemestane Study Group.
    Thürlimann B, Paridaens R, Serin D, Bonneterre J, Roché H, Murray R, di Salle E, Lanzalone S, Zurlo MG, Piscitelli G.
    Eur J Cancer; 1997 Oct 15; 33(11):1767-73. PubMed ID: 9470830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.